These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8546215)

  • 1. Altered neurofilament expression does not contribute to Lewy body formation.
    Bergeron C; Petrunka C; Weyer L; Pollanen MS
    Am J Pathol; 1996 Jan; 148(1):267-72. PubMed ID: 8546215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered neurofilament expression does not contribute to Lewy body formation.
    Hill WD
    Am J Pathol; 1996 Aug; 149(2):728-9. PubMed ID: 8702011
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease.
    Lu L; Neff F; Alvarez-Fischer D; Henze C; Xie Y; Oertel WH; Schlegel J; Hartmann A
    Exp Neurol; 2005 Sep; 195(1):27-39. PubMed ID: 15944136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit.
    Galvin JE; Lee VM; Baba M; Mann DM; Dickson DW; Yamaguchi H; Schmidt ML; Iwatsubo T; Trojanowski JQ
    Ann Neurol; 1997 Oct; 42(4):595-603. PubMed ID: 9382471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease.
    Iwatsubo T; Yamaguchi H; Fujimuro M; Yokosawa H; Ihara Y; Trojanowski JQ; Lee VM
    Am J Pathol; 1996 May; 148(5):1517-29. PubMed ID: 8623921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.
    Shepherd CE; McCann H; Thiel E; Halliday GM
    Neurobiol Dis; 2002 Mar; 9(2):249-57. PubMed ID: 11895376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of N-methyl-D-aspartate receptor subunit mRNA in the human brain: mesencephalic dopaminergic neurons.
    Counihan TJ; Landwehrmeyer GB; Standaert DG; Kosinski CM; Scherzer CR; Daggett LP; Veliçelebi G; Young AB; Penney JB
    J Comp Neurol; 1998 Jan; 390(1):91-101. PubMed ID: 9456178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
    Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
    Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor kappa-B p50 and p65 subunits expression in dementia with Lewy bodies.
    Saldaña M; Mullol J; Aguilar E; Bonastre M; Marin C
    Neuropathol Appl Neurobiol; 2007 Jun; 33(3):308-16. PubMed ID: 17442064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lewy body disease and dementia. A review.
    Kalra S; Bergeron C; Lang AE
    Arch Intern Med; 1996 Mar; 156(5):487-93. PubMed ID: 8604954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures.
    Park SS; Lee D
    Eur J Neurosci; 2006 Jun; 23(11):2908-14. PubMed ID: 16819979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology.
    Conn KJ; Gao W; McKee A; Lan MS; Ullman MD; Eisenhauer PB; Fine RE; Wells JM
    Brain Res; 2004 Oct; 1022(1-2):164-72. PubMed ID: 15353226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.
    Gai WP; Yuan HX; Li XQ; Power JT; Blumbergs PC; Jensen PH
    Exp Neurol; 2000 Dec; 166(2):324-33. PubMed ID: 11085897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lewy bodies, a misleading marker for Parkinson's disease?].
    Duyckaerts C; Hauw JJ
    Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease.
    Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
    Acta Neuropathol; 2003 Jul; 106(1):83-8. PubMed ID: 12687392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.